Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

Sun Pharmaceutical Industries Ltd. (SUN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,039.00 -1.00    -0.10%
05:00:03 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE044A01036 
S/N:  SUNPHARMA
  • Volume: 2,294,592
  • Bid/Ask: 1,037.80 / 1,038.00
  • Day's Range: 1,030.75 - 1,045.95
Sun Pharma 1,039.00 -1.00 -0.10%

SUN Income Statement

 
Featured here, the Income Statement (earnings report) for Sun Pharmaceutical Industries Ltd., showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2022
30/09
2022
30/06
2022
31/03
2021
31/12
Total Revenue 109522.8 107617.6 - 98630.6
Revenue 108091.9 106439.7 - 98141.7
Other Revenue, Total 1430.9 1177.9 - 488.9
Cost of Revenue, Total 27080.7 29002 - 26406.2
Gross Profit 82442.1 78615.6 - 72224.4
Total Operating Expenses 83642.1 86110.4 - 77998.2
Selling/General/Admin. Expenses, Total 20045.6 20748.5 - 18509.1
Research & Development 5583.7 4498.3 - 5224.2
Depreciation / Amortization - - 5564.7 5536.8
Interest Expense (Income) - Net Operating -193.9 -136.9 - -189.7
Unusual Expense (Income) - - 39357.5 -
Other Operating Expenses, Total 31126 31998.5 - 28048.4
Operating Income 25880.7 21507.2 - 20632.4
Interest Income (Expense), Net Non-Operating - - 1236.8 -295.6
Gain (Loss) on Sale of Assets - - - -
Other, Net 1799.1 -1316.6 - -3984.3
Net Income Before Taxes 24081.6 22823.8 - 24616.7
Provision for Income Taxes 1522.6 1889.9 - 3353.9
Net Income After Taxes 22559 20933.9 - 21262.8
Minority Interest 32461.8 - 30548.9 -674.8
Equity In Affiliates - - -50.2 -45.2
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 22622.2 20608.8 - 20588
Total Extraordinary Items - - - -
Net Income 22622.2 20608.8 - 20588
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 22622.2 20608.8 - 20588
Dilution Adjustment - - - -
Diluted Net Income 22622.2 20608.8 - 20588
Diluted Weighted Average Shares 2406.62 2396.37 - 2393.95
Diluted EPS Excluding Extraordinary Items 9.4 8.6 - 8.6
DPS - Common Stock Primary Issue - - - 7
Diluted Normalized EPS 6.28 5.82 - 6.14
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SUN Comments

Write your thoughts about Sun Pharmaceutical Industries Ltd.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bhuwan mohan
Bhuwan mohan Oct 09, 2022 4:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sunpharma sell stoploss 969 target 922 for 1 week
Ashish kumar jain
Ashish kumar jain Jul 27, 2022 1:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sunpharma tgt920/950
Modi Yogesh
Modi Yogesh Jun 27, 2022 7:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rajpal Choudhary
Rajpal Choudhary Mar 15, 2022 8:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SunPharma now on discounted rate(885-900)....buy and make a huge profit(950-970)
Gaurav Sharma
Gaurav Sharma Mar 07, 2022 2:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sunpharma buying opportunity...target 830
Soundararajan VS
Soundararajan VS Feb 03, 2022 10:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very soon go to 920
vaishnavi bhat
vaishnavi bhat Jan 27, 2022 9:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
850
bunty aulakh
bunty aulakh Jan 27, 2022 9:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
813 jayega
Anil Malakar
Anil Malakar Dec 29, 2021 1:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tomorrow 891 target
Anil Malakar
Anil Malakar Dec 23, 2021 4:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tomorrow sun pharma 835 target
rahil raza
rahil raza Dec 23, 2021 4:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
really you think that after seeing today performance
rahil raza
rahil raza Dec 23, 2021 4:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
really you think that after seeing today performance
Anil Malakar
Anil Malakar Dec 17, 2021 4:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
only one-man army in pharma
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email